INTRODUCTION
Herpesvirus infections are very frequent worldwide, with population prevalences reaching >90% in developing countries and >60% in developed countries. The most important biologic characteristic of these viruses is their capacity to establish lifelong latency after primary infection, with variable reactivation periods. [1] There are eight known human herpesviruses: herpes simplex viruses 1 and 2 (HSV); varicella-zoster virus (VZV); cytomegalovirus (CMV); Epstein-Barr (EBV); and human herpesviruses 6, 7 and 8 (HHV-6, HHV-7 and HHV-8). Most herpetic infections, primary as well as reactivations or reinfections, run their course asymptomatically. [2] [3] [4] The clinical spectrum varies widely, from acute, benign or self-limited diseases to more severe forms, particularly in immunosuppressed patients in which infection can lead to major complications or death. [2] [3] [4] [5] Of particular importance among these are febrile syndrome (FS) and mononucleosis-like syndrome (MLS), organ rejection accompanied by fever in transplant recipients, encephalitis, EBV-associated lymphomas, and congenital CMV disease. Herpesviruses are hence considered typically opportunistic pathogens. [6, 7] The situation is complicated when clinical manifestations are nonspeci¿ c, since different herpesviruses cause similar clinical presentations, making it dif¿ cult and laborious to reach a correct diagnosis. [8, 9] Serological tests have limited value, since they do not always permit diagnosis of active infection, especially in immunocompromised patients, in whom low levels of IgM are observed up to one or two years after infection. [10, 11] This is when molecular methods, such as polymerase chain reaction (PCR), become an alternative for rapid and highly sensitive differential diagnosis of active herpes infection. [10, 11] Because of the high frequency worldwide of patients seeking medical attention with mononucleosis and febrile syndromes of unknown etiology [12] and absence of previous reports in Cuba on the etiology of these syndromes, we carried out this ¿ rst study in Cuba of association between various herpesviruses and etiology of FS and MLS in immunocompetent and immunocompromised patients. This paper describes results from analysis of samples collected nationwide from such patients in whom herpetic disease was suspected.
METHODS
The Laboratory for Sexually Transmitted Diseases (Virology) (LSTD) of the Pedro Kourí Tropical Medicine Institute (IPK) is the only center in Cuba where samples are analyzed from patients with different clinical presentations and suspicion of herpetic etiology. These include MLS and acute or prolonged FS in immunocompetent patients or in patients with prior immunosuppressive diseases or conditions (such as cancer, HIV/AIDS, or organ transplant).
Study population Samples (1157) from 1140 patients were studied; 770 (66.5%) were urine samples and 387 (33.5%) serum. These were received at the IPK Laboratory for Sexually Transmitted Diseases (Virology) from January 2006 through December 2009. Samples came from patients evidencing MLS or FS and in whom active herpesvirus infection was suspected according to clinical history. Samples were divided into six groups according to clinical classi¿ cation, as shown in Table 1 . No samples with MLS were received from transplanted or other patients with immunosuppressive diseases.
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MLS cases were de¿ ned as patients whose main clinical signs were adenopathy in several lymph node chains, with or without hepatomegaly or splenomegaly. [13] FS cases were those with fever >38 °C for more than 3 days with no de¿ ned etiology and no signs of focalization. [14] Variables Life stage (adult or child), history of known immunode¿ -ciency, presenting syndrome suspected of herpetic etiology, PCR positivity (general to herpesviruses and to each one separately), and sample type were studied. All were qualitative nominal variables.
Samples Samples were 1-2 mL of serum or 5 mL of urine. All samples were received and stored at í20 °C at LSTD, after transportation to the Tropical Medicine Institute at 4 °C. Two samples (serum and urine) were studied in 17 patients.
DNA extraction DNA was extracted from the urine sample as follows: 10 ȝL of lysis solution (50 mM KCl, 10 mM Tris-HCl pH=9, 0.1% Triton X-100) and 0.5 ȝL of proteinase K (25 mg/ mL) were added to 39.5 ȝL of urine. These were incubated 45 minutes at 56 °C, after which proteinase K was inactivated by incubation at 95 °C for 10 minutes. Serum samples were processed using 300 ȝL of sample in a sterile vial, inactivating proteins at 95 °C for 10 minutes. Then 5 ȝL of the lysate were used for the ¿ rst PCR. [15] Conditions for ampli¿ cation PCR technique followed the protocol described by Tenorio et al. [15] Qualitative multiplex nested PCR enables genome detection of ¿ ve viruses of the herpesvirus family in only one reaction tube: HSV (without differentiating type 1 or 2), VZV, CMV, HHV-6 and EBV in two ampli¿ cation times or reactions. Primers amplify diverse regions of different human herpesviruses within a viral DNA polymerase fragment, as well as the pseudorabies virus (PRV), used as an internal control.
The ¿ rst reaction generates a 194 base-pair (bp) product, identical for all herpesvirus. For the nested reaction, 2 ȝL of the DNA ampli¿ ed in the ¿ rst reaction were used and a mixture of all typespeci¿ c primers (EUROGENTEC, USA), which allows generating different-sized products for each herpesvirus: PRV (140 bp), HSV1 or HSV2 (120 bp), VZV (98 bp), CMV (78 bp), HHV6 (66 bp) and EBV (54 bp). [15] Afterwards, the PCR product was observed in a 4% agarose gel in TBE solution (90 mM Tris-Borate, 2mM EDTA pH 8.0) stained with 0.5 mg/mL ethidium bromide. Runs were ended by evaluating apparent stain migration. Ampli¿ ed DNA band sizes were determined using a molecular weight standard (100 bp DNA ladder, Promega, USA) and known positive controls. The validity of each assay was con¿ rmed by ampli¿ cation of the internal control and two external controls: a negative one consisting of water instead of sample, and a positive one containing ampli¿ ed DNA polymerase fragment from any herpesvirus. [15] Statistical processing A database was created for analysis using the SPSS statistical package version 11.5. Positivity rates (percentages) were calculated for patients and samples. Odds ratios for positivity overall and for each herpesvirus were calculated by study group and clinical presentation, specifying a statistical signi¿ cance cut-off p value of <0.05 (with Yates' correction), as well as 95% con¿ dence intervals.
Ethical aspects
The study used samples and clinical information previously collected for management of FS or MLS cases with suspected herpetic etiology. The study design was approved by the Tropical Medicine Institute's ethics committee. Data management procedures ensured patient anonymity.
RESULTS
Samples studied came primarily from Havana City Province (74.6%); among the remaining 25.4% from other provinces, 8.4% came from Villa Clara and 6.6% from Santiago de Cuba. Sex distribution was balanced, with 53.8% of samples from female patients.
Of a total 1157 samples studied, 233 were PCR positive (161 urine, 72 serum), indicating active infection by some herpesvirus in 20.1% of samples, representing 20% of patients (228/1140). General positivity in MLS patient samples was 19.1%, slightly higher in children (20.9%) compared to adults, independent of adult HIV status (16.9% in immunocompetent and 17.7% in HIV-positive adults) ( Table 2) . Samples from FS patients were more likely to be positive for some herpesvirus than were samples from MLS patients (21.0%, 132/628 vs 19.1%, 101/529) ( Tables 2 and 3). CMV was the most frequently detected herpesvirus (62.2%, 145/233) ( Table 4) in samples of patients with active infections causing MLS (60.4%, 61/101) and FS (63.6%, 84/132) in all groups studied (Tables  2 and 3) , as well as in both children and adults (69.2%, 81/117 positive PCR in children and 55.2%, 64/116 in adults) ( Table 4) . Detection of CMV genome (active infection) was signi¿ cantly higher in children's samples than in those of adults (Table 5) .
EBV was the second most frequently PCR-detected virus, followed by HSV, HHV6 and VZV, with similar frequencies for both syndromes (Table 4) . (Tables 3 and  5) . Samples from immunocompromised children were more likely to be CMV-positive than those of immunocompromised adults (Table 5) .
Similar rates of overall PCR positivity were found in urine and serum samples (20.9%, 161/770, and 18.6%, 72/387 respectively). In positive samples, CMV was detected more often in urine (68.9%, 111/161) than in serum (47.9%, 34/72) ( Table  5 ). EBV was found in (23.6%, 17/72) of PCR-positive serum samples, followed by HSV (12.5%, 9/72), VZV (9.7%, 7/72) and HHV6 (6.9%, 5/72). PCR-positive serum samples came mainly from immunocompromised FS patients (69.4%, 50/72) and most PCR-positive sera were from patients with some level of immune response compromise (45.8%, 33/72) or children with likely primary herpetic infection (29.2%, 21/72).
Five samples were found with active herpesvirus co-infections, 80% of these in serum samples. One was from an FS HIVpositive patient with simultaneous detection of HHV6 and EBV. Another was from an immunocompetent adult with MLS in which VZV and HHV6 were detected. The remaining three were samples from children with MLS, in which HHV6 and CMV; CMV and EBV; and CMV were detected, respectively. In the last case, complicated by acute liver failure, VZV was also detected in serum.
DISCUSSION
MLS and FS may have different causes; most commonly infectious, particularly viral. Most cases are benign and selflimited, so the speci¿ c etiological agent is not sought. However, in patients with compromised immune response and in children with À orid clinical presentations, it is important to determine etiology to choose appropriate treatment. [16] Our study shows similar PCR-detected positivity levels to those reported in previous research using PCR to detect active herpesvirus infections in MLS patients. [17, 18] Although herpesvirus etiology was suspected in cases included in this study, these agents' pathogenesis (viral replication with viremia and viral excretion) takes place during approximately the ¿ rst two weeks of active infection, exact duration depending on whether it is a primary or recurrent infection and whether the patient is immunocompromised. Ten to 14 days after clinical onset, an immune response develops (humoral and cellular) resulting in virus clearance from À uids and viral latency. [2] [3] [4] [5] At that point, direct virologic diagnostic techniques (such as PCR and viral isolation) are not useful and serological techniques become important. [2] [3] [4] In this study, although slightly higher herpesvirus positivity was detected in samples from FS patients compared to those from MLS patients, the difference 
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was not statistically signi¿ cant. Most PCR-positive FS patients had prior immunosuppressive conditions (organ transplant, HIVpositivity or others). As reported internationally, these patients frequently present nonspeci¿ c FS associated with active herpesvirus infection, especially CMV but sometimes also by EBV, HSV and HHV6. [19] [20] [21] CMV was the most frequently detected herpesvirus for all groups studied. Active CMV infection was more frequent in children than in adults. Globally, CMV is widely distributed, with high prevalences in developing countries. [22, 23] Due to its tropism for endothelial cells and leucocytes, this virus is commonly found in many different cells and À uids, causing a wide range of clinical presentations. [24] Its frequency in this study was higher than classically stated, although diagnostic methods differ among the various studies. [25, 26] Banko et al. af¿ rm that PCR can be useful when speci¿ c serological tests do not lead to diagnosis, ¿ nding high rates of positivity in these cases. [17] CMV causes 8% of all MLS cases and 25-50% of MLS cases with negative humoral heterophile response in seroprevalence studies. [2] During primary infections, which generally occur during childhood, CMV produces viremia and is excreted in urine for longer periods of time than in recurrent infections. Similarly, CMV is replicated on a larger scale and for a longer time in immunocompromised patients. [2] EBV was detected in 16.3% of PCR-positive cases, lower than the rate reported in most of the literature reviewed. [17, 18] EBV has classically been associated with MLS, although it has also been associated with FS, both during primary and recurrent infections. [3] It is considered to cause 40% of all MLS cases, but most studies are based on serology rather than viral genome detection. [27] In this study, EBV was more frequently found in serum samples. During activation it can cause systemic infection and viremia, and may occasionally be excreted through the kidney. The importance and frequency of EBV are controversial and its detection in urine samples is not frequently described in the literature. [28] Higher PCR positivity occurs in immunocompromised patients because a deficient immune response, especially cellular, is accompanied by symptomatic primary infections and more frequent viral recurrences for longer periods, as well as by higher rates of viral replication at higher levels and with longer periods of viremia and viral excretion, facilitating detection by virological techniques, as other authors have previously demonstrated. [2, 11] Despite the availability of specific serological techniques for detecting antibodies to EBV, CMV and HSV, routinely used for studying MLS, [29, 30] serology is not recommended for MNS and FS diagnosis cases of deteriorated immune response, as in HIV-1 infection or after organ transplant.
The anomalous immune response in these patients may lead to errors in interpreting results. [31] Thus, the only suitable diagnostic tool in such cases is PCR. [32] Among the herpesviruses studied, CMV is the most opportunistic and the one with the worst effects, capable of further jeopardizing immune response and provoking life-threatening damage, [3, 30] hence its frequent and varied presentation in immunocompromised patients.
In this study, both urine and serum samples were useful for PCR herpesvirus detection. Our results are consistent with previous ¿ ndings that in all herpesviruses, viremia is associated with active viral replication and clinical disease, more evident in immunocompromised persons (since immune response is not ef¿ cient), or in those with primary infections (where immune response has not yet developed). [19, 21] Nevertheless, CMV's tropism for renal duct tubule epithelial cells, where active replication occurs, [2] makes urine samples best for detecting CMV excretion associated with viral replication, which can take place even in the absence of symptoms. [2, 33] Active co-infections were detected in ¿ ve patients. This has been observed in other recent studies by our group and other authors, both in central nervous system infections and in transplant recipients. [7, 34] Co-infections are frequently detected in immunocompromised patients. [35, 36] On the other hand, in immunocompetent patients with active infection by any herpesvirus, there is a temporary immunode¿ ciency that predisposes to activation of another herpesvirus infection. [3] The exact implications of co-infections for the pathogenesis of herpesvirus-associated diseases are not known. [37] Multiplex PCR, unlike conventional PCR, has the advantage of allowing simultaneous detection of several herpesviruses and thus the unique capability to identify patients with active co-infections. [38] One limitation of our research is that no specific serological studies were performed concurrently to detect antibodies against these herpesvirus agents, so cases of longer duration in which no viremia or active virus excretion was found remained undiagnosed. As suggested by other authors, [39] these results show how challenging it is to manage herpesvirus-caused MLS or FS, dealing as we are with viruses causing lifelong latent infections with intermittent periods of reactivation. [1] On one hand, there are serological diagnoses allowing identi¿ cation of prior exposure to viral infection (by presence of IgG-speci¿ c antibodies to a determined herpesvirus), or recent primary or recurrent infection (by presence of IgM-speci¿ c antibodies to a determined herpesvirus). On the other hand, there are direct virologic diagnostic methods-PCR or viral isolation-which are more precise and enable con¿ rmation of active viral infection, viremia, or excretion, depending on the type of sample studied and the pathogenesis of each herpesvirus.
CONCLUSIONS
The results of this study elucidate MLS and FS etiology in Cuban patients, as well as the pathogenic role of CMV, especially in immunocompromised patients. The importance is con¿ rmed of including molecular diagnosis of the herpesvirus family in studies of MLS and FS cases of unknown etiology. Without the use of PCR, etiologic diagnosis is impossible in many of these cases. PCR enables better medical management of these syndromes, leading the way to more speci¿ c treatment in cases of immunologic de¿ ciency that may lead to fatal outcomes and, in other cases, avoiding inappropriate antibiotic use.
We consider that complete diagnosis of herpesvirus infection associated with FS and MLS requires use of both virologic and serologic studies.
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